Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

RNAIII-inhibiting peptide TFA

🥰Excellent
Catalog No. TP1412
Alias RNAIII-inhibiting peptide(TFA)

RNAIII-inhibiting peptide TFA (RNAIII-inhibiting peptide(TFA))(228544-21-6 free base) inhibits S. aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.

RNAIII-inhibiting peptide TFA

RNAIII-inhibiting peptide TFA

🥰Excellent
Purity: 98.68%
Catalog No. TP1412Alias RNAIII-inhibiting peptide(TFA)
RNAIII-inhibiting peptide TFA (RNAIII-inhibiting peptide(TFA))(228544-21-6 free base) inhibits S. aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.
Pack SizePriceAvailabilityQuantity
1 mg$112In Stock
5 mg$359In Stock
10 mg$467In Stock
25 mg$606In Stock
50 mg$786In Stock
100 mg$1,020In Stock
200 mg$1,380In Stock
1 mL x 10 mM (in DMSO)$473In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "RNAIII-inhibiting peptide TFA"

Select Batch
Purity:98.68%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
RNAIII-inhibiting peptide TFA (RNAIII-inhibiting peptide(TFA))(228544-21-6 free base) inhibits S. aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.
In vitro
The RNAIII inhibiting peptide (RIP) is able to inhibit S. aureus pathogenesis by disrupting QS mechanism competing with RAP, thus inhibiting the phosphorylation of TRAP. This alteration leads to a reduced adhesion and to the inhibition of RNAIII synthesis, with the subsequent suppression of toxins synthesis.
AliasRNAIII-inhibiting peptide(TFA)
Chemical Properties
Molecular Weight1027.01
FormulaC47H57F3N10O13
SmilesC[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=C(C=C5)O)N)O.C(=O)(C(F)(F)F)O
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 150 mg/mL (146.06 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.9737 mL4.8685 mL9.7370 mL48.6850 mL
5 mM0.1947 mL0.9737 mL1.9474 mL9.7370 mL
10 mM0.0974 mL0.4869 mL0.9737 mL4.8685 mL
20 mM0.0487 mL0.2434 mL0.4869 mL2.4343 mL
50 mM0.0195 mL0.0974 mL0.1947 mL0.9737 mL
100 mM0.0097 mL0.0487 mL0.0974 mL0.4869 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy RNAIII-inhibiting peptide TFA | purchase RNAIII-inhibiting peptide TFA | RNAIII-inhibiting peptide TFA cost | order RNAIII-inhibiting peptide TFA | RNAIII-inhibiting peptide TFA chemical structure | RNAIII-inhibiting peptide TFA in vitro | RNAIII-inhibiting peptide TFA formula | RNAIII-inhibiting peptide TFA molecular weight